Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LLY

Lilly(Eli) & Co

Jun 20 • 04:00PM ET

762.73

Dollar change -22.30
Percentage change -2.84	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO SPY IVV VUG XLV VIG IWF QUAL VHT

Scroll to Statements

Index	S&P 500	P/E	63.19	EPS (ttm)	12.07	Insider Own	10.35%	Shs Outstand	948.10M	Perf Week	-6.07%
Market Cap	722.87B	Forward P/E	25.73	EPS next Y	29.65	Insider Trans	-0.89%	Shs Float	849.66M	Perf Month	2.10%
Income	11.11B	PEG	1.53	EPS next Q	5.56	Inst Own	73.61%	Short Float	0.94%	Perf Quarter	-9.48%
Sales	49.00B	P/S	14.75	EPS this Y	67.82%	Inst Trans	0.74%	Short Ratio	1.98	Perf Half Y	-2.09%
Book/sh	16.63	P/B	45.87	EPS next Y	36.00%	ROA	14.49%	Short Interest	8.03M	Perf Year	-13.82%
Cash/sh	3.40	P/C	224.44	EPS next 5Y	41.42%	ROE	77.73%	52W Range	677.09 - 972.53	Perf YTD	-1.20%
Dividend Est.	6.57 (0.86%)	P/FCF	193.46	EPS past 5Y	18.77%	ROIC	22.10%	52W High	-21.57%	Beta	0.39
Dividend TTM	5.60 (0.73%)	Quick Ratio	1.06	Sales past 5Y	15.08%	Gross Margin	81.70%	52W Low	12.65%	ATR (14)	21.06
Dividend Ex-Date	May 16, 2025	Current Ratio	1.37	EPS Y/Y TTM	80.73%	Oper. Margin	40.25%	RSI (14)	45.83	Volatility	0.89% 1.60%
Employees	47000	Debt/Eq	2.44	Sales Y/Y TTM	36.38%	Profit Margin	22.66%	Recom	1.52	Target Price	987.22
Option/Short	Yes / Yes	LT Debt/Eq	2.19	EPS Q/Q	23.46%	Payout	44.39%	Rel Volume	1.52	Prev Close	785.03
Sales Surprise	0.48%	EPS Surprise	2.51%	Sales Q/Q	45.17%	Earnings	May 01 BMO	Avg Volume	4.06M	Price	762.73
SMA20	-0.30%	SMA50	-1.93%	SMA200	-7.39%	Trades		Volume	6,175,623	Change	-2.84%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290

Show Previous Ratings

Today 09:06AM	Lilly expects orforglipron obesity results in third quarter (Reuters)
09:01AM	Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine (PR Newswire)
Jun-20-25 03:45PM	Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says (Reuters)
03:00PM	A $1.3 Billion Reason to Buy Eli Lilly Stock Now (Barchart)
01:07PM	Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week (Motley Fool)
12:49PM	Loading…
12:49PM	How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl (Investor's Business Daily)
09:30AM	Ricks Is the King of Pharma, Thanks to Lilly's Zepbound (Barrons.com)
09:28AM	LLY vs. ABBV: Which Pharma Powerhouse is the Better Bet? (Zacks)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:04AM	McDonald's Is Down, But Long-Term Investors Can Still Take a Bite (MarketBeat)
06:34AM	This AI Trader Bought Meta Stock and Dumped Eli Lilly (Barrons.com)
04:51AM	Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand (Reuters)
Jun-19-25 10:23AM	What is the Intent Behind Eli Lilly's Recent M&A Deals Spree? (Zacks)
09:45AM	SanDisk initiated, Analog Devices upgraded: Wall Streets top analyst calls (TipRanks)
08:03AM	RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome (PR Newswire)
07:55AM	Loading…
07:55AM	Eli Lilly and Eisais Alzheimers drugs denied NHS use due to high costs (Pharmaceutical Technology)
03:55AM	5 Growth Stocks to Invest $1,000 in Right Now (Motley Fool)
Jun-18-25 11:31PM	Q1 Earnings Outperformers: Eli Lilly (NYSE:LLY) And The Rest Of The Branded Pharmaceuticals Stocks (StockStory)
02:08PM	How a Solar Factory in the Heartland Sees the 'Big Beautiful Bill' (Barrons.com)
11:40AM	Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results (Investopedia)
10:52AM	Can Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space? (Zacks)
10:22AM	GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold? (Zacks)
10:00AM	Trump administration weighs crackdown on pharma ads, Bloomberg says (TipRanks)
09:53AM	Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside. (Motley Fool)
09:35AM	Gene-Editing Stocks Gain on LLY-VERV Deal Announcement (Zacks)
07:45AM	Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy? (Motley Fool)
03:37AM	Adam Parker of Trivariate Research Recommends Eli Lilly's Dividend as a Defensive Play (Insider Monkey)
Jun-17-25 05:49PM	Podcast: U.S. Stocks Slip as Israel-Iran Conflict Continues (The Wall Street Journal)
04:34PM	These Stocks Moved the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and More (Barrons.com)
03:59PM	Solar stocks, Eli Lilly & Verve, PureCycle: Trending Tickers (Yahoo Finance Video)
02:47PM	Loading…
02:47PM	These Stocks Are Moving the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and More (Barrons.com)
01:28PM	Eli Lilly lands bargain deal to acquire Verve Therapeutics for $1.3bn (Pharmaceutical Technology)
01:27PM	Lilly to buy gene-editing partner Verve for $1.3 billion (CNBC TV)
12:57PM	Citi initiates coverage on biotech amid improving sentiment in sector (Investing.com)
12:12PM	Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly (Zacks)
12:03PM	Top Stock Movers Now: Enphase Energy, T-Mobile US, Jabil, and More (Investopedia)
11:20AM	UBS Maintains Price Target on Eli Lilly (LLY) Despite CVS Shift to Wegovy (Insider Monkey)
11:18AM	AMD extends gains, solar stocks plummet, pharma stocks (Yahoo Finance Video)
11:08AM	Eli Lilly to buy Verve Therapeutics for up to $1.3 Billion (GuruFocus.com)
11:05AM	Why Verve Therapeutics Stock Is Skyrocketing Today (Motley Fool)
10:02AM	Eli Lillys $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know. (Barrons.com)
09:53AM	T-Mobile & Softbank, solar, Eli Lilly & Verve: Trending Tickers (Yahoo Finance Video)
09:33AM	Members of Congress Are Pouring Millions Into These 7 Surprising Stocks (Motley Fool)
09:15AM	Verve Therapeutics Skyrockets - Pulling Gene-Editing Stocks Higher - On $1.3 Billion Eli Lilly Takeover (Investor's Business Daily)
08:14AM	Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B (Investopedia)
08:13AM	This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly (MarketWatch)
07:55AM	Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion (The Wall Street Journal)
07:01AM	This Stock Jumps 77% After $1.3 Billion Bid From Eli Lilly (Barrons.com)
06:45AM	Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk (PR Newswire)
05:54AM	Green energy stocks stumble, and other early market movers (MarketWatch)
05:33AM	Eli Lilly Close to $1.3 Billion Bid for Biotech, Says Report. Verve Therapeutics Stock Soars 80%. (Barrons.com)
02:23AM	Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform (Insider Monkey)
12:18AM	Eli Lilly's Dividend May Be Small, But its Growth Tells a Bigger Story (Insider Monkey)
Jun-16-25 07:49PM	Eli Lilly strikes $1.3 billion deal to buy gene-editing biotech Verve Therapeutics, companies say (Reuters)
05:45PM	Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts (Zacks)
12:35PM	Novo Nordisk Stock Rises 6% in a Week: What Should Investors Do? (Zacks)
12:01PM	Could Meta and Eli Lilly Trigger the Next Stock Split Boom? (MarketBeat)
11:40AM	HTO or CWST: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	VNT vs. DUOL: Which Stock Is the Better Value Option? (Zacks)
11:40AM	PFE or LLY: Which Is the Better Value Stock Right Now? (Zacks)
07:45AM	The Zacks Analyst Blog Highlights Eli Lilly, Home Depot, SAP and Natural Resource Partners (Zacks)
07:04AM	3 Growth Stocks You Can Buy Right Now Without Any Hesitation (Motley Fool)
06:45AM	Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions (PR Newswire)
06:00AM	Eli Lilly CFOs on-stage comment shows the high stakes of public speaking: Trial Balance (CFO.com)
Jun-15-25 10:00AM	Pharma manufacturing 'boom' faces high costs, potential delays (Yahoo Finance)
07:30AM	Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock? (Motley Fool)
05:46AM	Goldman Sachs Remains a Buy on Eli Lilly (LLY) With an $883 Price Target (Insider Monkey)
05:22AM	Jim Cramer on Eli Lilly: "We Like It" (Insider Monkey)
Jun-14-25 04:40AM	1 Growth Stock Down 9% to Buy Right Now (Motley Fool)
Jun-13-25 04:31PM	Top Analyst Reports for Eli Lilly, Home Depot & SAP (Zacks)
12:58PM	Novo Nordisk Is Europe's Most Valuable Company-Again. Eli Lilly, Watch Out. (Barrons.com)
12:45PM	Senators to propose ban on drug ads to consumers, WSJ reports (TipRanks)
10:41AM	Lilly Moves Past 50-Day Average: Should You Buy the Stock Now? (Zacks)
10:00AM	Tariffs Create Most Patriotic Earnings Season Yet as US Firms Pander to Trump (Bloomberg)
09:08AM	NVO Stock up on Plans to Advance Obesity Candidate Amycretin (Zacks)
03:10AM	Down 12%, Should You Buy the Dip on Eli Lilly? (Motley Fool)
Jun-12-25 02:12PM	Abbott Laboratories Stock Sees RS Rating Rise To 82 (Investor's Business Daily)
Jun-11-25 10:57AM	Trump Wants Cheaper Drugs Like Europe Has. How It Works. (Barrons.com)
10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
10:00AM	NVO Stock Gains After Parvus Asset Management Builds Stake (Zacks)
09:38AM	Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space? (Zacks)
09:32AM	Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to (Yahoo Finance)
06:20AM	Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? (Zacks)
06:20AM	Should You Invest in the iShares U.S. Healthcare ETF (IYH)? (Zacks)
04:23AM	Should You Buy Eli Lilly Stock Before June 22? (Motley Fool)
03:13AM	The cheap fat jabs sending big pharma into a frenzy (The Telegraph)
Jun-10-25 04:27PM	Eli Lilly telehealth deals to prevent sale of compounded GLP-1s (Yahoo Finance Video)
03:35PM	Hims & Hers stock falls after Lilly rules out partnership (Investing.com)
02:03PM	Drug pricing reform talks with US government lack clarity, industry executives say (Reuters)
01:56PM	Energy and healthcare stocks power S&P 500 higher (MarketWatch)
11:10AM	Novo Nordisk Stock Climbs on Report of Activist Investor Parvus Building Stake (Investopedia)
10:23AM	Top Cancer Stocks to Supercharge Your 2025 Portfolio (Zacks)
09:02AM	Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE? (Zacks)
08:27AM	Weight-Loss Drugs Pose Long-Term Threat To McDonald's: Analyst (Investor's Business Daily)
08:27AM	McDonald's Stock Bitten By Big Downgrade Over Weight-Loss Drugs (Investor's Business Daily)
08:19AM	Scorpion, fresh off Lilly deal, spins out startup Antares (BioPharma Dive)
03:33AM	2 Weight Loss Drug Stocks That Are Screaming Buys in June (Motley Fool)
Jun-09-25 08:59PM	Eli Lilly Bets $870 Million on Extended-Release Obesity Drugs (GuruFocus.com)
04:08PM	Obesity Newcomer Metsera Enters The Ring With A Punch And A Big Stock Jump (Investor's Business Daily)
12:05PM	Eli Lilly and Company (LLY): A Bull Case Theory (Insider Monkey)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience